Global Drug Eluting Balloons (DEBs) Market is expected to grow at a significant
CAGR in the upcoming years as the scope, product types and its applications are
increasing across the globe. A Drug Eluting Balloons (DEBs), are also termed as
a drug-coated balloons (DCBs). The paclitaxel is also used with Drug Eluting
Balloons (DEBs) for treating Femoral/Popliteal lesions (peripheral), lesions in
tortuous vessels (coronary), in-stent re-stenos is (coronary), Bifurcation
lesions (coronary), below knee lesions (peripheral).
Drug Eluting Balloons (DEBs)help in widening of arteries;
which have narrowed due to the above-mentioned diseases. In addition,
increasing occurrence of coronary artery diseases, obesity, peripheral artery
diseases, and diabetes will drive the demand for drug eluting balloons.
Drug Eluting Balloons (DEBs) Market is categorized based on
product type, applications, and geography. Drug Eluting Balloons (DEBs)
Industry is categorized based on product types such as Paccocath Balloons,
SeQuent Please Balloons, In. Pact Falcon Balloons, and DIOR Balloons. Drug
Eluting Balloons (DEBs) Market is categorized based on application into
Coronary Artery Diseases, Peripheral Artery Diseases, Obesity and Diabetes,
Others.
Drug Eluting Balloons (DEBs) Market is categorized based on
geography into Asia Pacific (China, India, ASEAN, Australia & New Zealand),
Japan, Middle East and Africa (GCC countries, S. Africa, Rest Of MEA), North
America (U.S., Canada), Latin America (Brazil, Rest of Latin America), Western
Europe (Germany, Italy, France, England, Spain, Rest of Western Europe), and
Eastern Europe (Poland, Russia, Rest of Eastern Europe).
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/drug-eluting-balloons-debs-market
North America has been at the forefront with regards to Drug
Eluting Balloons (DEBs) Market and will continue to rule the roost in the years
to come. Some of the key players that fuel the growth of the Drug Eluting
Balloons (DEBs) Market include B. Braun Melsungen AG, EurocorGmBH, C.R. Bard,
Inc., Cook Medical, Inc., Medtronic, Inc. and Aachen Resonance GmBH. The key players
are focusing on inorganic growth to sustain themselves amidst fierce
competition. As such, mergers, acquisitions, and joint ventures are the need of
the hour.
Market
Segment:
Geographically,
this report is segmented into several key Regions, with production,
consumption, revenue (million USD), market share and growth rate of Drug
Eluting Balloons (DEBs) in these regions, from 2012 to 2022 (forecast),
covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
Global
Drug Eluting Balloons (DEBs) market competition by top manufacturers, with
production, price, revenue (value) and market share for each manufacturer; the
top players including
• B. Braun Melsungen
• Cook Medical
• C.R. Bard
• Eurocor
• Medtronic
• Aachen Resonance
• Acrostak
• Cardionovum
• Spectranetics
• B. Braun Melsungen
• Cook Medical
• C.R. Bard
• Eurocor
• Medtronic
• Aachen Resonance
• Acrostak
• Cardionovum
• Spectranetics
Request Sample Copy of this Market
Research @ https://www.millioninsights.com/industry-reports/drug-eluting-balloons-debs-market/request-sample
Comments
Post a Comment